SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-06-014414
Filing Date
2006-11-21
Accepted
2006-11-21 15:15:54
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 a2174699zs-3.htm S-3 198738
2 EXHIBIT 5.1 a2174699zex-5_1.htm EX-5.1 5449
3 EXHIBIT 23.2 a2174699zex-23_2.htm EX-23.2 2090
4 EXHIBIT 23.3 a2174699zex-23_3.htm EX-23.3 1885
5 EXHIBIT 99.1 a2174699zex-99_1.htm EX-99.1 14795
6 EXHIBIT 99.2 a2174699zex-99_2.htm EX-99.2 8189
7 EXHIBIT 99.3 a2174699zex-99_3.htm EX-99.3 9678
8 EXHIBIT 99.4 a2174699zex-99_4.htm EX-99.4 15449
9 EXHIBIT 99.5 a2174699zex-99_5.htm EX-99.5 50797
10 EXHIBIT 99.6 a2174699zex-99_6.htm EX-99.6 16653
11 EXHIBIT 99.7 a2174699zex-99_7.htm EX-99.7 35256
12 G747769.JPG g747769.jpg GRAPHIC 33742
  Complete submission text file 0001047469-06-014414.txt   407063
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-138862 | Film No.: 061232723
SIC: 2835 In Vitro & In Vivo Diagnostic Substances